These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 25265433

  • 1. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.
    Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen C.
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):239-44. PubMed ID: 25265433
    [Abstract] [Full Text] [Related]

  • 2. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 3. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 4. Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.
    Wu YC, Chang IC, Wang CL, Chen TD, Chen YT, Liu HP, Chu Y, Chiu YT, Wu TH, Chou LH, Chen YR, Huang SF.
    PLoS One; 2013 Jul; 8(8):e70839. PubMed ID: 23951022
    [Abstract] [Full Text] [Related]

  • 5. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
    Pekar-Zlotin M, Hirsch FR, Soussan-Gutman L, Ilouze M, Dvir A, Boyle T, Wynes M, Miller VA, Lipson D, Palmer GA, Ali SM, Dekel S, Brenner R, Bunn PA, Peled N.
    Oncologist; 2015 Mar; 20(3):316-22. PubMed ID: 25721120
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
    Demidova I, Barinov A, Savelov N, Gagarin I, Grinevitch V, Stroiakovaski D, Popov M, Laktionov K, Gutorov S, Smolin A, Olshanskaya Y, Obukhova T.
    Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
    [Abstract] [Full Text] [Related]

  • 7. [ALK fusion gene assessment by fully automatic immunohistochemistry in non-small cell lung cancer].
    Guo L, Liu X, Qiu T, Ling Y, Shan L, Xie Y.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):95-8. PubMed ID: 24742568
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
    Conklin CM, Craddock KJ, Have C, Laskin J, Couture C, Ionescu DN.
    J Thorac Oncol; 2013 Jan; 8(1):45-51. PubMed ID: 23196275
    [Abstract] [Full Text] [Related]

  • 9. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
    V Laffert M, Warth A, Penzel R, Schirmacher P, Jonigk D, Kreipe H, Schildhaus HU, Merkelbach-Bruse S, Büttner R, Reu S, Kerler R, Jung A, Kirchner T, Wölfel C, Petersen I, Rodriguez R, Jochum W, Bartsch H, Fisseler-Eckhoff A, Berg E, Lenze D, Dietel M, Hummel M.
    Lung Cancer; 2013 Aug; 81(2):200-6. PubMed ID: 23669200
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
    Zhang YG, Jin ML, Li L, Zhao HY, Zeng X, Jiang L, Wei P, Diao XL, Li X, Cao Q, Tian XX.
    PLoS One; 2013 Aug; 8(5):e64821. PubMed ID: 23741400
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.
    Cruz-Rico G, Avilés-Salas A, Segura-González M, Espinosa-García AM, Ramírez-Tirado LA, Morales-Oyarvide V, Rojas-Marín C, Cardona AF, Arrieta O.
    Am J Clin Oncol; 2017 Dec; 40(6):631-638. PubMed ID: 26270443
    [Abstract] [Full Text] [Related]

  • 12. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
    Alì G, Proietti A, Pelliccioni S, Niccoli C, Lupi C, Sensi E, Giannini R, Borrelli N, Menghi M, Chella A, Ribechini A, Cappuzzo F, Melfi F, Lucchi M, Mussi A, Fontanini G.
    Arch Pathol Lab Med; 2014 Nov; 138(11):1449-58. PubMed ID: 24885803
    [Abstract] [Full Text] [Related]

  • 13. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
    Li W, Zhang J, Guo L, Chuai S, Shan L, Ying J.
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [Abstract] [Full Text] [Related]

  • 14. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH, Choe G, Kim H, Choe JY, Lee HJ, Lee CT, Lee JS, Jheon S, Chung JH.
    J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
    [Abstract] [Full Text] [Related]

  • 15. Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK-rearranged non-small cell lung cancer (NSCLC).
    Shen Q, Wang X, Yu B, Shi S, Liu B, Wang Y, Xia Q, Rao Q, Zhou X.
    Lung Cancer; 2015 Dec; 90(3):492-8. PubMed ID: 26477969
    [Abstract] [Full Text] [Related]

  • 16. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.
    BMC Cancer; 2018 Nov 22; 18(1):1158. PubMed ID: 30466405
    [Abstract] [Full Text] [Related]

  • 17. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA, Frohnauer J, Merkelbach-Bruse S, Schildhaus HU, Dimmler A, Schubert T, Boltze C, König H, Fuchs F, Sirbu H, Rieker RJ, Agaimy A, Hartmann A, Haller F.
    Lung Cancer; 2014 Jun 22; 84(3):215-21. PubMed ID: 24674157
    [Abstract] [Full Text] [Related]

  • 18. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z.
    Mol Cancer Res; 2009 Sep 22; 7(9):1466-76. PubMed ID: 19737969
    [Abstract] [Full Text] [Related]

  • 19. Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer.
    Houang M, Toon CW, Clarkson A, Sioson L, Watson N, Farzin M, Selinger CI, Chou A, Morey AL, Cooper WA, O'Toole SA, Gill AJ.
    Pathology; 2014 Aug 22; 46(5):383-8. PubMed ID: 24842379
    [Abstract] [Full Text] [Related]

  • 20. Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.
    Rogers TM, Russell PA, Wright G, Wainer Z, Pang JM, Henricksen LA, Singh S, Stanislaw S, Grille J, Roberts E, Solomon B, Fox SB.
    J Thorac Oncol; 2015 Apr 22; 10(4):611-8. PubMed ID: 25789833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.